Key terms

About SANA

Sana Biotechnology, Inc. engages in the research and development of engineered cells as medicine. It focuses on identifying and developing potential product candidates, executing preclinical studies, and acquiring technology. The company was founded by Steven D. Harr, Noubar B. Afeyan, Robert Taylor Nelsen, and Hans Edgar Bishop on July 2018 and is headquartered in Seattle, WA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest SANA news

Yesterday 5:12pm ET Sana Biotechnology EVP and President of R&D Resigns Mar 01 4:10pm ET Sana Biotechnology files automatic mixed securities shelf Mar 01 6:29am ET Sana Biotechnology: Buy Rating Affirmed Amid Anticipation of Clinical Breakthroughs and Hypoimmune Platform Validation Mar 01 6:28am ET Sana Biotechnology: Promising Clinical Prospects and Buy Rating Justified by Upcoming Data Readouts Mar 01 6:21am ET Sana Biotechnology price target raised to $15 from $8 at JMP Securities Mar 01 12:30am ET Wall Street Analysts Are Bullish on Top Healthcare Picks Feb 29 8:20pm ET Analysts Offer Insights on Healthcare Companies: Privia Health Group (PRVA) and Sana Biotechnology (SANA) Feb 29 4:15pm ET Sana Biotechnology reports Q4 EPS (45c), consensus (38c) Feb 16 8:06am ET Viridian Therapeutics names Jennifer Tousignant chief legal officer Feb 15 6:20am ET Wall Street Analysts Are Bullish on Top Healthcare Picks Feb 13 4:47pm ET Sana Biotechnology publishes HIP-modified pancreatic islet cells data Feb 09 5:16am ET Sana Biotechnology Announces Pricing of Upcoming Offering Feb 09 5:15am ET Sana Biotechnology’s Major Public Offering Agreement Feb 08 6:04am ET Sana Biotechnology 17.3M share Spot Secondary priced at $5.50 Feb 08 4:35am ET Sana Biotechnology Previews Preliminary Financials and Trial Progress Feb 07 4:03pm ET Sana Biotechnology announces $125M common stock offering

No recent press releases are available for SANA

SANA Financials

1-year income & revenue

Key terms

SANA Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

SANA Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms